The analysis of the NSCLC cohort showed an immunosuppressive tumor microenvironment characterized principally by the axis of PD-L1/PD-1 and their interaction with different cellular subpopulations; this axis continues to be an important therapeutic target in many types of cancer5. The gene discussed is PDCD1; the disease is neoplasm.